The World Health Organization has said that based on current data, BQ.1 and BQ.1.1 appear to be more infectious than previous variants but are no more likely to cause serious illness or death…
There was good news on Monday from Moderna MRNA, +4.57%, which said both of its new COVID boosters produced a better antibody response against the BA.4 and BA.5 variants in a Phase 2/3 clinical than the company’s original booster.
DB2
Long MRNA